RenovoRx RNXT
NASDAQ RNXT
$1.28 -0.04 (-3.04%)
As of: Aug 21, 2026 · 10:50 AM EDT

RenovoRx (RNXT) EBITDA Margin Growth (1y) (2026)

RenovoRx (RNXT) EBITDA Margin Growth (1y) (2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA Margin Growth (1y) (Qtr)
1 Vertex Pharmaceuticals 139.40 Bn 131.55 Bn 2.84 Bn -143.00
2 Regeneron Pharmaceuticals 86.53 Bn 78.54 Bn 3.93 Bn 78.00
3 Argenx Se 65.20 Bn 60.02 Bn 1.37 Bn 1,135.00
4 Moderna 60.40 Bn 55.26 Bn 52.00 Mn 7,666.00
5 BeOne Medicines 42.17 Bn 37.07 Bn 1.53 Bn 1,238.00
6 Alnylam Pharmaceuticals 31.36 Bn 28.05 Bn 992.69 Mn 2,002.00
7 BioNTech SE 28.74 Bn 10.34 Bn 668.28 Mn -3,558.00
8 Insmed 27.45 Bn 26.29 Bn 358.27 Mn 29,091.00
9 Royalty Pharma 27.17 Bn 26.33 Bn - -1,651.00
10 RenovoRx 60.54 Mn 60.54 Mn 766,000.00 26,617.00

Historic Data

Download Data
DateValue
Jun 30, 2026 26,617.00
Mar 31, 2026 96,252.00